Tag: venous thromboembolism

Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

Prolonged TV watching may increase risk of venous thromboembolism

A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...

Six-month registry interim data flash early thrombectomy safety in pulmonary embolism...

Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism patients enrolled in the FlowTriever outcomes registry (FLASH). A...

Meta-analysis: IVC filters should be considered for certain patients at high...

In a recent meta-analysis, Yang Liu, Huan Lu (Henan Cancer Hospital, Zhengzhou, China), and colleagues found insufficient evidence to prove that inferior vena cava...
COVID-19

New study addresses thromboembolic complications in COVID-19 patients

There is an “urgent need” to improve specific venous thromboembolism (VTE) diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19...
guideline

Updated VTE treatment guideline for patients with cancer revealed by ASCO

An updated guideline on the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer has been unveiled by the American Society of...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...